Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Morena D'Alise

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in Oncology|February 1, 2023
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategyAnna Morena D'Alise, Elisa Scarselli
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletionMarlys S Fassett, Wenyu Jiang, Anna Morena D'Alise, et al.
The Journal of Cell Biology|July 14, 2010
Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversineStefano Santaguida, Anthony Tighe, Anna Morena D'Alise, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2011
A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD miceAnna Morena D'Alise, Ayla Ergun, Jonathan A Hill, et al.
Seminars in Immunology|December 2, 2020
New viral vectors for infectious diseases and cancerEmanuele Sasso, Anna Morena D'Alise, Nicola Zambrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
The defect in T-cell regulation in NOD mice is an effect on the T-cell effectorsAnna Morena D'Alise, Vincent Auyeung, Markus Feuerer, et al.
Expert Review of Vaccines|April 9, 2013
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trialsStefania Capone, Anna Morena D'Alise, Virginia Ammendola, et al.
International Journal of Molecular Sciences|December 9, 2023
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of CancerLaura Seclì, Guido Leoni, Valentino Ruzza, et al.
Scientific Reports|September 13, 2019
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular SignallingMargherita Passariello, Anna Morena D'Alise, Annachiara Esposito, et al.
Molecular Cancer Therapeutics|May 17, 2008
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cellsAnna Morena D'Alise, Giovanni Amabile, Mariangela Iovino, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|February 1, 2023
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategyAnna Morena D'Alise, Elisa Scarselli
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletionMarlys S Fassett, Wenyu Jiang, Anna Morena D'Alise, et al.
The Journal of Cell Biology|July 14, 2010
Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversineStefano Santaguida, Anthony Tighe, Anna Morena D'Alise, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2011
A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD miceAnna Morena D'Alise, Ayla Ergun, Jonathan A Hill, et al.
Seminars in Immunology|December 2, 2020
New viral vectors for infectious diseases and cancerEmanuele Sasso, Anna Morena D'Alise, Nicola Zambrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
The defect in T-cell regulation in NOD mice is an effect on the T-cell effectorsAnna Morena D'Alise, Vincent Auyeung, Markus Feuerer, et al.
Expert Review of Vaccines|April 9, 2013
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trialsStefania Capone, Anna Morena D'Alise, Virginia Ammendola, et al.
International Journal of Molecular Sciences|December 9, 2023
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of CancerLaura Seclì, Guido Leoni, Valentino Ruzza, et al.
Scientific Reports|September 13, 2019
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular SignallingMargherita Passariello, Anna Morena D'Alise, Annachiara Esposito, et al.
Molecular Cancer Therapeutics|May 17, 2008
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cellsAnna Morena D'Alise, Giovanni Amabile, Mariangela Iovino, et al.
Pageof 4